Fulcrum Therapeutics Inc FULC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:52 PM EST
6.34quote price arrow down-0.21 (-3.13%)
Volume
166,931
52 week range
3.21 - 24.79
Loading...
  • Open6.60
  • Day High6.76
  • Day Low6.28
  • Prev Close6.55
  • 52 Week High24.79
  • 52 Week High Date04/05/22
  • 52 Week Low3.21
  • 52 Week Low Date06/10/22

Key Stats

  • Market Cap330.266M
  • Shares Out52.05M
  • 10 Day Average Volume0.33M
  • Dividend-
  • Dividend Yield-
  • Beta1.94
  • YTD % Change-64.22

KEY STATS

  • Open6.60
  • Day High6.76
  • Day Low6.28
  • Prev Close6.55
  • 52 Week High24.79
  • 52 Week High Date04/05/22
  • 52 Week Low3.21
  • 52 Week Low Date06/10/22
  • Market Cap330.266M
  • Shares Out52.05M
  • 10 Day Average Volume0.33M
  • Dividend-
  • Dividend Yield-
  • Beta1.94
  • YTD % Change-64.22

RATIOS/PROFITABILITY

  • EPS (TTM)-2.56
  • P/E (TTM)-2.48
  • Fwd P/E (NTM)-2.97
  • EBITDA (TTM)-105.214M
  • ROE (TTM)-47.44%
  • Revenue (TTM)10.715M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,000.65%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date03/01/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Fulcrum Therapeutics Inc

Profile

MORE
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on improving the lives of patients with genetically defined rare diseases. The Company has developed a product engine which identifies drug targets which can modulate gene expression to treat the known root cause of gene mis-expression. The Company is also engaged in developing drugs for the treatment for the root cause of muscle disorders, central nervous system disorders and blood...
Kate Haviland
Independent Chairman of the Board
Bryan Stuart
President, Chief Executive Officer, Director
Mel Hayes
Chief Operating Officer
Esther Rajavelu
Chief Financial Officer
Curtis Oltmans J.D.
General Counsel
Address
26 Landsdowne St
Cambridge, MA
02139-4216
United States

Top Peers

SYMBOLLASTCHG%CHG
ARDX
Ardelyx Inc
1.70-0.05-2.86%
AADI
Aadi Bioscience Inc
13.33+0.19+1.45%
LQDA
Liquidia Corp
4.90+0.06+1.24%
ETNB
89Bio Inc
7.76-0.05-0.61%
KNTE
Kinnate Biopharma Inc
7.51-0.10-1.25%